Company: ANIX
Filing Date: 2025-09-10
Form Type: 10-Q
Source: 0001493152-25-013000
Chunk: 21

Company: Anixa Biosciences Inc
Filing Date: 2025-09-10
Form: 10-Q
Item: Part I, Item 1
Chunk 21
---
41  

    Exercised 
     (35,000) 
     2.09  

    Forfeited/expired 
     (90,000) 
     3.54  

    Options
    outstanding at July 31, 2025 
     12,476,094  
    $3.59  
    $1,707 
  
    Options
    exercisable at July 31, 2025 
     8,943,235  
    $3.61  
    $972 

The
following table summarizes information about stock options outstanding and exercisable under the 2018 Share Plan as of July 31, 2025:

 SCHEDULE OF OPTIONS OUTSTANDING AND EXERCISABLE

    Options
    Outstanding  
    Options
    Exercisable 
  
    Range
    of  Exercise Prices  
    Number
     Outstanding  
    Weighted
     Average  Remaining  Contractual Life  (in years)  
    Weighted
     Average  Exercise Price  
    Number
     Exercisable  
    Weighted
     Average  Remaining  Contractual Life  (in years)  
    Weighted
     Average  Exercise Price 
  
    $
    2.09
    - $3.87  
     6,638,879  
     5.7  
    $3.06  
     5,439,960  
     5.0  
    $3.19 
  
    $
    4.02
    - $5.30  
     5,837,215  
     6.7  
    $4.20  
     3,503,275  
     6.6  
    $4.25 

Employee
Stock Purchase Plan

The
Company maintains the Anixa Biosciences, Inc. Employee Stock Purchase Plan (the “ESPP”) which permits eligible employees
to purchase shares at not less than 85% of the market value of the Company’s common stock on the offering date or the purchase
date of the applicable semi-annual offering period, whichever is lower. The ESPP was adopted by our Board of Directors on August 13,
2018 and approved by our shareholders on September 27, 2018. During the nine months ended July 31, 2025 and 2024,